Oscient EVP for corporate development and operations resigns
WALTHAM, Mass. An executive at Oscient Pharmaceuticals has resigned to take a new job, Oscient announced on Tuesday, Dec. 16.
EVP for corporate development and operations Dominick Colangelo will provide business development consulting services to Oscient through Jan. 31, 2009, with the potential for an extension. He will be entitled to consulting fees, as well as an incentive for completion of certain business development objectives that the company did not specify.
VP of corporate development Anthony Watkins will direct all business development efforts, reporting directly to president and CEO Steve Rauscher.
Gilead sues Teva over approval application for generic Truvada
NEW YORK Gilead Sciences has filed a lawsuit against Israeli generic drug maker Teva Pharmaceutical Industries and a subsidiary.
Gilead, which filed the suit Friday in a United States District Court in New York, alleged that Teva committed patent infringement when it filed an approval application with the Food and Drug Administration for a generic version of Truvada (emtricitabine), a drug for treating HIV.
Gilead has a license to manufacture and sell the drug from Emory University in Atlanta.
Take Care adds another clinic to its network in Miami/Fort Lauderdale area
CONSHOHOCKEN, Pa. Take Care Health Systems, which is owned by Walgreens, has opened one new clinic in the Miami/South Fort Lauderdale area. The opening marks the 10th Take Care Clinic in the market.
The company currently operates 313 clinics in 18 states.